Executive Profile

Mark R. Bamforth Founder, Chief Executive Officer, President and Director, Gallus Biopharmaceuticals, LLC

Age	Total Calculated Compensation	This person is connected to 2 Board Members in 2 different organizations across 4 different industries. See Board Relationships
--	--

Background

Mr. Mark R. Bamforth founded Gallus Biopharmaceuticals, LLC in 2010 and serves as its Chief Executive Officer and President. Mr. Bamforth serves as Senior Vice President of Genzyme Molecular Oncology. Mr. Bamforth is responsible for product supply from Genzyme's twelve GMP manufacturing sites located in Europe, USA and Australia, which produce some 20 commercial, regulated products using biological, small molecule, therapeutic polymer, cell, tissue and biomaterial device ... technologies. He served as the Senior Vice President of Corporate Operations and Pharmaceuticals of Genzyme Corporation since May 2004. He served as Senior Vice President of Corporate Operations at Genzyme Oncology, Inc. from May 2001 to May 2004. He joined Genzyme in 1988 as Vice President and General Manager of Genzyme's operations in the United Kingdom. He was responsible for the centralized support functions of Quality & Technical Operations and Materials Management which support all of Genzyme’s sites and businesses, including management of the capacity strategy with an investment of $300-400M p.a. to develop internal manufacturing capacity and infrastructure. In addition, he is responsible for the Pharmaceutical Business Unit which has a manufacturing operation in Liestal, Switzerland and sells specialty chemicals and drug delivery technologies to the biotechnology and pharmaceutical industry and manufactures clinical materials for Genzyme development products. Before joining Genzyme in 1988, he served as a Drilling Engineer in the North Sea offshore oil industry and then as a Chemical Engineer in the whisky industry in Scotland. He serves as a Director of Gallus Biopharmaceuticals, LLC. Mr. Bamforth serves as a Member of Advisory Board of Scottish Development International. He serves on the Massachusetts Biotechnology Council Board, University College London's (UCL) Department of Biochemical Engineering's Advisory Board and on Scottish Enterprise's International Advisory Board. Mr. Bamforth has a BSc. Honors in Chemical Engineering from Strathclyde University and an MBA from Henley Business School.

Corporate Headquarters 4766 LaGuardia Drive St. Louis, Missouri 63134-3117 United States Phone: 314-426-5000 Fax: 314-733-3888 Board Members Memberships Founder, Chief Executive Officer, President and Director Gallus Biopharmaceuticals, LLC Education BS University of Strathclyde MBA Henley Business School Other Affiliations Genzyme Corporation Genzyme Oncology, Inc. University of Strathclyde Henley Business School Scottish Development International Ltd.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.